Wikipedia
BioMotiv
BioMotiv is an accelerator company associated with The Harrington Project, a national initiative centered at University Hospitals of Cleveland. The company is designed to accelerate breakthrough discoveries into medicines by advancing a portfolio of novel therapeutics in all disease areas and types of therapeutics — small molecules, antibodies, proteins, cell therapies, and nucleotides – from the discovery to pre-clinical stages of development and will also consider drug re-purposing opportunities. Opportunities are sourced primarily through relationships with research institutions and disease foundations.